Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 13
  1. May 28, 2026 · 16:40 · PINK · Neutral

    Perimeter Medical Imaging AI

    Perimeter Announces First Quarter 2026 Financial Results

    01
  2. May 28, 2026 · 16:15 · BHC · Routine +

    Solta Trademark Win Reinforces China Growth Narrative Amidst Elevated Debt Costs and Xifaxan LOE Clock

    Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage(TM) in China

    02
  3. May 28, 2026 · 16:00 · SHRX · Routine +

    Sharp Therapeutics Expands NPC Pipeline with Preclinical Data Amidst Ongoing Capital Raise

    Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C

    03
  4. May 28, 2026 · 14:50 · 4568 · Routine +

    Daiichi Sankyo’s Vanflyta secures Canadian public reimbursement, a measured step in global AML market access.

    Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta(TM) in Newly Diagnosed FLT3-ITD Positive AML

    04
  5. May 28, 2026 · 13:44 · NGMD · Routine +

    Micro-cap device firm advances IP portfolio amid regulatory headwinds

    NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance

    05
  6. May 28, 2026 · 09:10 · MDNA · Routine +

    Medicenna Secures $12.4M Lifeline Amidst Dilution Concerns and Clinical Milestones

    Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs

    06
  7. May 28, 2026 · 08:00 · CNVI · Neutral

    FDA Clearance Delivered But Dilution and Cash Burn Threaten Near-Term Stability

    Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights

    07
  8. May 28, 2026 · 07:31 · CHER · Routine +

    Cheelcare Secures Canadian IP Moat as Sales Momentum Builds Amidst Dilution Risks

    Cheelcare Receives Canadian Patent for Companion Power Assist Platform

    08
  9. May 28, 2026 · 07:15 · ASG · Routine +

    Aurora Spine Stabilizes Operations with First EBITDAC Profit, Yet Revenue Stagnation and Cash Burn Raise Liquidity Concerns

    Aurora Spine Corporation Announces First Quarter FY26 Financial Results

    09
  10. May 28, 2026 · 07:00 · LSL · Routine +

    Revenue Growth Masks Profitability Concerns as Operational Scaling Continues

    LSL PHARMA GROUP SECURES NEW STERI-MED COMMERCIAL AGREEMENTS EXPECTED TO GENERATE OVER $4 MILLION IN RECURRING ANNUAL REVENUES AND APPOINTS ALAIN R. DUGAL AS NEW EVP & COO

    10
  11. May 28, 2026 · 00:11 · ZYUS · Material −

    ZYUS Slides into Limbo as Cease Trade Order Grinds Operations, While a Trickle of Insider Loans Can’t Mask a Race Against Time

    ZYUS Life Sciences Corporation Announces Closing of Second Tranche of Secured Loan Financing and Provides an Update on its Annual Filings and Q1 2026 Financial Statement

    11
  12. May 27, 2026 · 18:00 · GUD · Routine +

    LATAM Expansion Validates Growth Strategy But FX and Generic Risks Loom

    Knight Therapeutics Announces Launch of TAVALISSE(TM) in Mexico

    12
  13. May 27, 2026 · 16:00 · INNO · Material −

    Innocan’s Revenue Rebound Is No Match for a Shelved U.S. IPO as Cash Burn Leaves a Bitter Aftertaste

    Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M

    13
  14. May 27, 2026 · 08:01 · PHRM · Routine +

    PharmaTher Evolves Platform Strategy with MEDBOTX(TM) Robotic 3D Printing for Personalized Medicines

    PharmaTher Evolves Platform Strategy with MEDBOTX(TM) Robotic 3D Printing for Personalized Medicines

    14
← Newer Older →